FNDC5 and endothelial dysfunction: In HFpEF, irisin deficiency correlates with diastolic dysfunction, increased arterial stiffness, and poor exercise capacity, while experimental administration of recombinant irisin ameliorates endothelial dysfunction and cardiac remodeling by stimulating AMPK–eNOS and Akt–ERK pathways [76,79,80].